TickerFacts.

Neurocrine Biosciences Inc (NBIX): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

Older than the company's other figures. The latest EBITDA is for the year ended 2018-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report Depreciation & Amortization, which EBITDA is computed from, under the concepts TickerFacts maps.

$40.82M
Year ended 2018-12-31
2009-12-31: -$50.49M2010-12-31: -$12.29M2011-12-31: $34.62M2012-12-31: $2.10M2013-12-31: -$49.01M2014-12-31: -$63.58M2015-12-31: -$93.19M2016-12-31: -$145.92M2017-12-31: -$128.96M2018-12-31: $40.82M$40.82M
2009-12-31 EBITDA (USD) 2018-12-31
Period endedEBITDAChange YoYSource filing
2018-12-31$40.82Mn/m2021-02-05, From 2018-01-01
2017-12-31-$128.96Mn/m2020-02-07, From 2017-01-01
2016-12-31-$145.92Mn/m2019-02-08, From 2016-01-01
2015-12-31-$93.19Mn/m2018-02-13, From 2015-01-01
2014-12-31-$63.58Mn/m2017-02-14, From 2014-01-01
2013-12-31-$49.01Mn/m2016-02-11, From 2013-01-01
2012-12-31$2.10M-93.9%2015-02-09, From 2012-01-01
2011-12-31$34.62Mn/m2014-02-11, From 2011-01-01
2010-12-31-$12.29Mn/m2013-02-08, From 2010-01-01
2009-12-31-$50.49Mn/a2012-02-09, From 2009-01-01